Cargando…

Serum Triglyceride Lipase Concentrations are Independent Risk Factors for Coronary Artery Disease and In-Stent Restenosis

Aim: Endothelial lipase (EL), hepatic lipase (HL), and lipoprotein lipase (LPL) are all triglyceride lipases and are associated with coronary artery disease (CAD). However, whether they can be simultaneous independent risk factors for CAD is unknown. In the present study, we investigated whether the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xiaolan, Lu, Jianping, Li, Jingjing, Guan, Wen, Deng, Shaorong, Deng, Qing, Ye, Hao, Han, Wei, Yu, Yan, Zhang, Ruiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753239/ https://www.ncbi.nlm.nih.gov/pubmed/30651409 http://dx.doi.org/10.5551/jat.46821

Ejemplares similares

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
por: Zhu, Yong, et al.
Publicado: (2021)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
por: Demyanets, Svitlana, et al.
Publicado: (2014)

Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
por: Han, Hui, et al.
Publicado: (2019)

Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention
por: Guo, Xuantong, et al.
Publicado: (2023)

Association of serum apoA-I with in-stent restenosis in coronary heart disease
por: Wang, Xin, et al.
Publicado: (2022)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Association of Triglyceride Deposit Cardiomyovasculopathy With Drug-Eluting Stent Restenosis Among Patients With Diabetes
por: Nakano, Yusuke, et al.
Publicado: (2020)

Large-scale gene analysis of rabbit atherosclerosis to discover new biomarkers for coronary artery disease
por: Yu, Xiaolan, et al.
Publicado: (2019)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Cerebral collateral circulation as an independent predictor for in-stent restenosis after carotid artery stenting
por: Liu, Luji, et al.
Publicado: (2023)

Diagnostic value of intraluminal stent enhancement in estimating coronary in-stent restenosis
por: Nogourani, Mehdi Karami, et al.
Publicado: (2020)

Coated stents to prevent restenosis in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2005)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Treatment of coronary in-stent restenosis: a systematic review
por: Pleva, Leos, et al.
Publicado: (2018)

Diagnosis and management challenges of in-stent restenosis in coronary arteries
por: Alraies, M Chadi, et al.
Publicado: (2017)

Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
por: Lin, Xiao Long, et al.
Publicado: (2022)

Association between skeletal muscle mass and serum concentrations of lipoprotein lipase, GPIHBP1, and hepatic triglyceride lipase in young Japanese men
por: Matsumoto, Ryutaro, et al.
Publicado: (2019)

Inflammation and In-Stent Restenosis: The Role of Serum Markers and Stent Characteristics in Carotid Artery Stenting
por: Wasser, Katrin, et al.
Publicado: (2011)

Nanotechnology for the treatment of coronary in stent restenosis: a clinical perspective
por: McDowell, Garry, et al.
Publicado: (2011)

Differential Expression of miRNA-223 in Coronary In-Stent Restenosis
por: Ganjali, Shiva, et al.
Publicado: (2022)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
por: Hu, Huilin, et al.
Publicado: (2021)

Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management
por: Abouelnour, Amr, et al.
Publicado: (2022)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis
por: Joo, Hyung Joon, et al.
Publicado: (2018)

Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study
por: Zhang, Juan, et al.
Publicado: (2022)

In-stent restenosis and longitudinal stent deformation: a case report
por: Si, Daoyuan, et al.
Publicado: (2020)

New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent
por: Wang, Jian-Long, et al.
Publicado: (2018)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis
por: Yin, Rui-Xing, et al.
Publicado: (2014)

Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty
por: Sajadian, Mostafa, et al.
Publicado: (2018)

Coronary Angioscopy Findings before and after Excimer Laser Coronary Angioplasty for Bare-Metal Stent In-Stent Restenosis
por: Masuda, Shinichiro, et al.
Publicado: (2019)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent Implantation
por: Qin, Zheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1622l5q9c6g3frnrui9lomh90i